Distribution territories and causative mechanisms of ischemic stroke.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 15657788)

Published in Eur Radiol on January 19, 2005

Authors

A Rovira1, E Grivé, A Rovira, J Alvarez-Sabin

Author Affiliations

1: Hospital Vall d'Hebron, Unidad de Resonancia Magnetica, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. alex.rovira@idi-cat.org

Articles citing this

Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. AJNR Am J Neuroradiol (2013) 1.71

Clinical evaluation of bone-subtraction CT angiography (BSCTA) in head and neck imaging. Eur Radiol (2005) 1.03

Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol (2013) 0.99

Diffusion-weighted MR imaging in transient ischaemic attacks. Eur Radiol (2006) 0.94

Usefulness of high-b-value diffusion-weighted imaging in acute cerebral infarction. Eur Radiol (2006) 0.92

Brainstem and cerebellar changes after cerebrovascular accidents: magnetic resonance imaging. Eur Radiol (2005) 0.86

Differences in videofluoroscopic swallowing study (VFSS) findings according to the vascular territory involved in stroke. Dysphagia (2014) 0.86

Carotid plaque computed tomography imaging in stroke and nonstroke patients. Ann Neurol (2008) 0.83

Actual diagnostic approach to the acute stroke patient. Eur Radiol (2005) 0.82

Comparison of the new ASCO classification with the TOAST classification in a population with acute ischemic stroke. J Neurol (2011) 0.81

Stroke radiology and distinguishing characteristics of intracranial atherosclerotic disease in native South Asian Pakistanis. Int J Stroke (2012) 0.80

Large-vessel stenosis in the patients with ischemic stroke in Iran: Prevalence, pattern, and risk factors. J Vasc Interv Neurol (2015) 0.80

DWI Lesion Patterns in Cancer-Related Stroke - Specifying the Phenotype. Cerebrovasc Dis Extra (2015) 0.78

Baseline NIH stroke scale responses estimate the probability of each particular stroke subtype. Cerebrovasc Dis (2008) 0.76

Adult moyamoya disease in an urban center in the United States is associated with a high burden of watershed ischemia. J Am Heart Assoc (2014) 0.75

Stroke in children with cardiac disease: report from the International Pediatric Stroke Study Group Symposium. Pediatr Neurol (2014) 0.75

Ischaemic stroke as initial presentation of systemic malignancy. BMJ Case Rep (2014) 0.75

Magnetic Resonance Perfusion Imaging Provides a Significant Tool for the Identification of Cardioembolic Stroke. Curr Neurovasc Res (2016) 0.75

The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers. Angiology (2012) 0.75

Distribution, Severity and Radiologic Features of Intracranial Stenosis in Asymptomatic Pakistanis. Austin J Cerebrovasc Dis Stroke (2015) 0.75

Feasibility and Diagnostic Accuracy of Ischemic Stroke Territory Recognition Based on Two-Dimensional Projections of Three-Dimensional Diffusion MRI Data. Front Neurol (2015) 0.75

Articles cited by this

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81

Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30

Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke (2001) 4.87

Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke (2000) 2.59

Arterial territories of the human brain: cerebral hemispheres. Neurology (1998) 2.47

Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology (1998) 2.25

Centrum ovale infarcts: subcortical infarction in the superficial territory of the middle cerebral artery. Neurology (1992) 1.62

Arterial territories of human brain: brainstem and cerebellum. Neurology (1996) 1.59

Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke (2000) 1.57

Significance of acute multiple brain infarction on diffusion-weighted imaging. Stroke (2000) 1.57

Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke (1990) 1.45

Infarcts in the anterior choroidal artery territory. Anatomical distribution, clinical syndromes, presumed pathogenesis and early outcome. Brain (1994) 1.43

Multiple acute stroke syndrome: marker of embolic disease? Neurology (2000) 1.40

Very small (border zone) cerebellar infarcts. Distribution, causes, mechanisms and clinical features. Brain (1993) 1.35

Two clinically distinct lacunar infarct entities? A hypothesis. Stroke (1993) 1.35

Atrial fibrillation and stroke : concepts and controversies. Stroke (2001) 1.27

Two types of lacunar infarcts: further arguments from a study on prognosis. Stroke (2002) 1.24

Variability of the territories of the major cerebral arteries. J Neurosurg (1992) 1.13

Borderzone infarctions distal to internal carotid artery occlusion: prognostic implications. Ann Neurol (1986) 1.11

Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases. Stroke (2003) 1.10

Acute stroke patterns in patients with internal carotid artery disease: a diffusion-weighted magnetic resonance imaging study. Stroke (2001) 1.10

Causes and mechanisms of territorial and nonterritorial cerebellar infarcts in 115 consecutive patients. Stroke (1994) 1.06

Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke (2000) 0.95

Atherothrombotic middle cerebral artery territory infarction: topographic diversity with common occurrence of concomitant small cortical and subcortical infarcts. Stroke (2000) 0.93

Internal borderzone infarction: a marker for severe stenosis in patients with symptomatic internal carotid artery disease. For the North American Symptomatic Carotid Endarterectomy (NASCET) Group. Stroke (2000) 0.92

Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke (2002) 0.90

Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke (2002) 0.90

Brain infarction severity differs according to cardiac or arterial embolic source. Neurology (1993) 0.88

Mechanisms and clinical features of posterior border-zone infarcts. Neurology (1999) 0.84

Atherothrombotic cerebellar infarction: vascular lesion-MRI correlation of 31 cases. Stroke (1999) 0.80

Extent and location of cerebral infarcts on multiplanar MR images: correlation with distribution of perforating arteries on cerebral angiograms and on cadaveric microangiograms. AJR Am J Roentgenol (1994) 0.78

Articles by these authors

MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology (2007) 2.47

Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology (2008) 2.45

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol (2000) 2.10

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology (2003) 2.04

[Effectiveness of smoking cessation intervention in patients with cardiovascular disease]. Rev Esp Cardiol (2001) 1.93

MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90

Pituitary enlargement in patients with intracranial hypotension syndrome. Neurology (2000) 1.71

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63

Lumbar extradural hemangiomas: report of three cases. AJNR Am J Neuroradiol (1999) 1.55

Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler (2009) 1.49

Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology (2006) 1.42

[Role of homocysteine in the acute phase of stroke]. Neurologia (2004) 1.40

[Body mass index influence in the insulin action mechanisms]. An Med Interna (1998) 1.38

[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study]. Med Clin (Barc) (1997) 1.37

Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27

Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26

Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology (2002) 1.25

Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients. Mult Scler (2008) 1.21

A care bundle approach for prevention of ventilator-associated pneumonia. Clin Microbiol Infect (2012) 1.17

High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology (2004) 1.13

MRI findings in Möbius syndrome: correlation with clinical features. Neurology (2000) 1.13

Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer (2006) 1.11

Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry (2011) 1.10

mTOR signalling in human cancer. Clin Transl Oncol (2007) 1.09

Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Neurology (2006) 1.09

Brainstem lesions in clinically isolated syndromes. Neurology (2010) 1.09

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. Br J Cancer (2011) 1.06

Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage. Neurology (2011) 1.06

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler (2009) 1.04

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology (2007) 1.04

Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia (1995) 1.04

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04

Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler (2008) 1.03

Patulin accumulation in apples by Penicillium expansum during postharvest stages. Lett Appl Microbiol (2007) 1.02

Automatic detection of patients with nosocomial infection by a computer-based surveillance system: a validation study in a general hospital. Infect Control Hosp Epidemiol (2006) 1.00

Clinical impact of early brain atrophy in clinically isolated syndromes. Mult Scler (2013) 1.00

Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology (1999) 0.99

The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99

One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.99

A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. Neurology (2010) 0.98

Asterixis associated with anatomic cerebral lesions: a study of 45 cases. Acta Neurol Scand (1995) 0.98

Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98

C-MET as a new therapeutic target for the development of novel anticancer drugs. Clin Transl Oncol (2010) 0.98

Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol (2001) 0.97

Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol (1991) 0.97

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler (2013) 0.97

Cerebral microembolism in acute spontaneous internal carotid artery dissection. Neurology (2000) 0.96

Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. Cerebrovasc Dis (2012) 0.95

The proteasome: a novel target for anticancer therapy. Clin Transl Oncol (2006) 0.95

DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer. Oncogene (2010) 0.94

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.94

MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique? Neurology (2011) 0.94

Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: A case-control study. Stroke (1999) 0.94

Stimulation of glucose transport by thyroid hormone in 3T3-L1 adipocytes: increased abundance of GLUT1 and GLUT4 glucose transporter proteins. J Endocrinol (2000) 0.94

Increased glucose transporter (GLUT4) protein expression in hyperthyroidism. Biochem Biophys Res Commun (1990) 0.93

A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses (1996) 0.92

[Vertebrobasilar abnormalities in patients with hemifacial spasm: MR-angiography findings]. Rev Neurol (1999) 0.92

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis. Mult Scler (2010) 0.91

Radiologic findings in two cases of acute Schmörl's nodes. AJNR Am J Neuroradiol (1999) 0.91

Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K+ channel dependent mechanism. Diabetologia (1996) 0.91

Caspase-3 is related to infarct growth after human ischemic stroke. Neurosci Lett (2007) 0.90

Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol (2008) 0.90

Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis. Neuroimage (2008) 0.89

Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. AJNR Am J Neuroradiol (2007) 0.89

Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis (1999) 0.89

An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis. Rev Neurol (2011) 0.89

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler (2001) 0.89

Mutagenesis of lysine 460 in the human insulin receptor. Effects upon receptor recycling and cooperative interactions among binding sites. J Biol Chem (1990) 0.89

Neuropsychological profile of bilateral paramedian infarctions: three cases. Neurocase (2011) 0.89

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis. Mult Scler (2009) 0.88

Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia (2011) 0.88

MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice. AJNR Am J Neuroradiol (2011) 0.88

Scleredema diabeticorum in a patient with type 2 diabetes mellitus. Case Rep Endocrinol (2011) 0.87

Growth of abnormal neurites in atypical Alzheimer's disease. A study with the Golgi method. Acta Neuropathol (1983) 0.87

Retrospective study on porcine circovirus type 2 infection in pigs from 1985 to 1997 in Spain. J Vet Med B Infect Dis Vet Public Health (2003) 0.86

Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol (2013) 0.86

Clinical practice guidelines in intracerebral haemorrhage. Neurologia (2011) 0.86

Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients. Br J Cancer (2010) 0.86

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler (2003) 0.86

Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Cerebrovasc Dis (2009) 0.86

Posterior fossa reconstruction: a surgical technique for the treatment of Chiari I malformation and Chiari I/syringomyelia complex--preliminary results and magnetic resonance imaging quantitative assessment of hindbrain migration. Neurosurgery (1994) 0.85

Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding. Neurology (2009) 0.85

[Intracranial involvement in neurosarcoidosis: a report of 4 cases as initial manifestation of the disease]. Rev Neurol (1999) 0.85

Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus. Diabetes Metab Res Rev (2000) 0.85

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS. Mult Scler (2013) 0.85

Spontaneous ventriculostomy: report of three cases revealed by flow-sensitive phase-contrast cine MR imaging. AJNR Am J Neuroradiol (1999) 0.85

Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data. Neurology (2005) 0.84

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis. J Neurol (2008) 0.84